Skip to main content

Table 1 Comparison of OCS participants’ characteristics between the participating and non-participating sites in the representativeness study

From: Representativeness of an HIV cohort of the sites from which it is recruiting: results from the Ontario HIV Treatment Network (OHTN) cohort study

 

All sites

4 sites in representativeness study

Other sites

 

Characteristics

 

(n=3106)

(n=1861)

(n=1245)

p value

Age

 

46 (40–52)

46 (40–52)

46 (40–52)

0.77

Male

 

2628 (85%)

1632 (88%)

996 (80%)

<.0001

Risk factor

     
 

MSM

2133 (71%)

1429 (77%)

704 (60%)

<.0001

 

IDU

364 (12%)

180 (10%)

184 (16%)

<.0001

 

heterosexual

629 (21%)

325 (18%)

304 (26%)

<.0001

 

Blood product/MTCT

197 (6%)

102 (5%)

95 (8%)

0.009

Race

    

0.02

 

Caucasian

2170 (72%)

1329 (72%)

841 (72%)

 
 

Black/African

418 (14%)

259 (14%)

159 (14%)

 
 

Aboriginal

161 (5%)

83 (4%)

78 (7%)

 
 

Other

264 (9%)

176 (10%)

88 (8%)

 

Born in Canada

 

2090 (69%)

1264 (69%)

826 (70%)

0.35

Years since HIV+ test

 

11 (6–17)

12 (5–18)

11 (6–17)

0.41

Cigarette history

    

0.006

 

Never

1017 (35%)

623 (35%)

394 (35%)

 
 

Former

736 (25%)

479 (27%)

257 (23%)

 
 

Current

1161 (40%)

671 (38%)

490 (43%)

 

Alcohol use

 

1102 (38%)

718 (40%)

384 (34%)

0.0003

Substance use

 

614 (21%)

414 (23%)

200 (18%)

0.0002

Education

    

<.0001

 

High school or lower

929 (32%)

504 (28%)

425 (37%)

 
 

Some/completed college

890 (30%)

545 (31%)

345 (30%)

 
 

Some/completed university

1102 (38%)

732 (41%)

370 (32%)

 

Employed

 

1401 (48%)

920 (52%)

481 (42%)

<.0001

Household income

    

<.0001

 

< 30 K

1062 (40%)

566 (35%)

496 (47%)

 
 

30-60 K

612 (23%)

378 (24%)

234 (22%)

 
 

60-80 K

298 (11%)

189 (12%)

109 (10%)

 
 

> 80 K

693 (26%)

470 (29%)

223 (21%)

 

General health

    

<.01

 

Good

2353 (81%)

1466 (82%)

887 (78%)

 
 

Fair

464 (16%)

248 (14%)

216 (19%)

 
 

Poor

103 (4%)

65 (4%)

38 (3%)

 

On cART

 

2497 (80%)

1487 (80%)

1010 (81%)

0.40

CD4 count (cells/mm3)

 

471 (330–650)

480 (340–650)

460 (310–649)

0.02

VL < 50 copies/mL

 

2254 (73%)

1379 (74%)

875 (70%)

0.02

  1. OCS Ontario HIV Treatment Network Cohort Study, MSM men who have sex with men, IDU injection drug use, MTCT mother to child transmission, cART combination antiretroviral therapy, VL viral load.
  2. Numbers are reported as median (interquartile range) or frequency (percentage).